JATT II Acquisition Corp is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands in 2026. As a blank check company, its primary business model is to raise capital through an initial public offering and use the proceeds to identify, acquire, and merge with an existing private operating company, thereby taking the target company public. The company does not currently have any active business operations and does not generate operating revenue, with its capital held in a trust account pending a successful transaction. JATT II Acquisition Corp intends to focus its search for a business combination target within the healthcare and healthcare-related industries. Specifically, the company is targeting businesses in the biotechnology and broader life sciences sectors, with a particular interest in companies applying data-driven approaches such as machine learning, computational biology, and structure-based drug design to improve therapeutic discovery and development. The company's leadership team brings experience from the life sciences industry to identify clinical-stage assets and novel technologies. If the company fails to complete a business combination within its allotted timeframe, it will be required to liquidate and return funds to its shareholders.